Welcome to our dedicated page for Jupiter Wellness news (Ticker: SHOTW), a resource for investors and traders seeking the latest updates and insights on Jupiter Wellness stock.
Jupiter Wellness Inc (SHOTW) delivers innovative CBD solutions through brands like Canisun sun care and Canidermrx dermatological treatments. This news hub provides investors and industry observers with essential updates on therapeutic product developments, regulatory milestones, and strategic initiatives.
Access timely announcements covering clinical research progress, distribution partnerships, and financial performance. Our curated feed simplifies tracking of SHOTW's advancements in hemp-derived wellness products while maintaining strict compliance with financial disclosure standards.
Key updates include CBD formulation innovations, market expansion efforts, and scientific collaborations. Bookmark this page for direct access to original press releases and verified news about Jupiter Wellness' position in the evolving cannabinoid health sector.
Safety Shot, Inc. (Nasdaq: SHOT) has reported groundbreaking clinical results for its rapid alcohol reducer. The double-blind, randomized, placebo-controlled study showed that Safety Shot not only significantly decreases blood alcohol content (BAC) in as little as 30 minutes but also rapidly reduces acetaldehyde in the blood, the main cause of unpleasant after-effects from heavy drinking.
The study demonstrated a substantial increase in aldehyde dehydrogenase and a marked decrease in acetaldehyde, proving that Safety Shot can effectively remove alcohol-related toxins faster than the body's natural processes. This breakthrough addresses the root cause of morning-after symptoms, which is acetaldehydes, not dehydration.
Safety Shot's patented formula is available in a 12oz drink, 4oz shot, and dry powder stick pack, positioning the company as a leader in combating alcohol's negative effects.
Safety Shot, Inc. (Nasdaq: SHOT), the company behind the world's first alcohol detoxifier, has announced a partnership with VENDO, a leading e-commerce platform. This strategic move aims to significantly boost Safety Shot's online presence and brand growth. VENDO, known for its expertise in Amazon and Walmart marketplaces, will help Safety Shot navigate the rapidly expanding e-commerce landscape, which was valued at $6.9 trillion in 2024.
Safety Shot's President, Jordan Schur, expressed enthusiasm about the partnership, highlighting VENDO's reputation as the best team in the business. VENDO CEO Darren Saul emphasized their commitment to helping Safety Shot reach a wider audience through seamless online shopping experiences across various platforms.
Safety Shot, Inc. (Nasdaq: SHOT) reported strong Q2 2024 results, with a 40% increase in sales and a 17.7% decrease in operating expenses compared to Q1. The company's recent clinical trial demonstrated significant efficacy in reducing Blood Alcohol Content (BAC), showing a 30%-50% faster rate of alcohol reduction within 30 minutes of consumption compared to placebo.
Safety Shot announced new product formats, including 4-ounce bottles launching in Q3 and a powdered version in Q4. The company also secured partnerships with Capital Drugs, expanding to 300 pharmacies nationwide, and Mr. Checkout for wider distribution. Additional partnerships include GoPuff and BevMo, enhancing market presence.
Safety Shot, Inc. (Nasdaq: SHOT) has announced significant findings from a recent clinical trial conducted at The Center for Applied Health Sciences. The study evaluated the impact of Safety Shot on Blood Alcohol Content (BAC) and demonstrated remarkable results. Within 30 minutes of consuming Safety Shot, participants showed a 30%-50% faster rate of alcohol reduction compared to the placebo group.
Key findings include:
- Consistent lowering of breath alcohol content
- Significant improvements in BAC, ethanol, acetaldehyde, and aldehyde dehydrogenase levels
- Reduced head discomfort, fatigue, and improved concentration
The study results are being prepared for peer review and publication in a biomedical journal. Safety Shot aims to revolutionize the wellness space with its innovative approach to responsible alcohol consumption.
Safety Shot, Inc. (Nasdaq: SHOT) is set to launch a powdered version of its alcohol-reducing nutraceutical in early Q4. The product, available in convenient stick pack format, maintains 100% efficacy of the original formula. This expansion addresses the growing global stick packaging market, projected to reach $517.61 million by 2031.
The powder stick packs will be offered in packs of 6, with some locations providing single stick options. This new format aims to increase brand visibility, expand retail presence, and broaden the customer base. Safety Shot's innovative product is designed to reduce blood alcohol content in as little as 30 minutes, offering a portable solution for consumers on the go.
Safety Shot, Inc. (Nasdaq: SHOT) has announced a strategic partnership with KeHE Distributors, a leading natural and organic food distributor in North America. This collaboration aims to expand Safety Shot's nationwide presence and enhance consumer accessibility. KeHE's network of over 6,800 employee-owners and 19 distribution centers will help deliver Safety Shot's products to thousands of new retail locations across the United States.
Josh Wager, Safety Shot's Chief Revenue Officer, expressed excitement about the partnership, highlighting its potential to bring Safety Shot to a broader audience. This distribution milestone follows recent partnerships with Atlantic Beverage Distributors and Prime CSB, further expanding Safety Shot's market reach to meet increased demand.
Safety Shot (Nasdaq: SHOT) has terminated its partnership with professional boxer Ryan Garcia due to remarks that were deemed discriminatory. The company, which maintains a strict zero-tolerance policy towards any form of hate speech, has officially severed all ties with Garcia. CEO Jarrett Boon emphasized the importance of brand ambassadors aligning with the company's core values, expressing disappointment in Garcia's behavior but wishing him well in his rehabilitation efforts. The termination underscores Safety Shot's commitment to upholding its ethical standards.
Safety Shot President Jordan Schur has made a $1 million private placement investment in the company through his family fund, Core 4 Capital Corp. This follows a prior $5 million investment by Core 4 Capital Corp in April 2024, coinciding with Schur's appointment as President. The recent investment involved the issuance of 943,396 shares at $1.06 per share, the closing price of Safety Shot's common stock, with no discount or attached warrants. The company incurred minimal expenses and paid no commissions, ensuring nearly all proceeds directly benefit Safety Shot. Schur expressed confidence in the company's growth and product innovation, highlighting the investment's potential to fuel further development.
Safety Shot announced the addition of comedian and actor Drew “Druski” Desbordes as a brand ambassador. Druski, popular for his sketch comedy, has over 7.7 million Instagram followers and 6.8 million on TikTok. He has collaborated with various artists and appeared in numerous music videos, movies, and TV shows. Safety Shot aims to leverage Druski's reach and relatable content to boost brand awareness and consumer loyalty. Safety Shot is a unique beverage designed to rapidly rehydrate and reduce blood alcohol content within 30 minutes.
Safety Shot (Nasdaq: SHOT) has announced a strategic partnership with Chip Quigley of Kingdom Entertainment Group and Ari Freedman of Surge Brands to enhance its marketing, events, brand development, and distribution. Quigley brings over two decades of experience in entertainment and marketing, while Freedman specializes in brand growth and market penetration. This collaboration aims to elevate Safety Shot’s presence through innovative events and expanded distribution channels. This partnership follows Safety Shot's recent Northeast expansion and collaborations with Mr. Checkout, Capital Drugs, GoPuff, and BevMo.